醫療保健生物融合市場規模、佔有率、趨勢分析報告：按應用、地區、細分市場預測，2025-2030 年

Healthcare Bioconvergence Market Size, Share & Trends Analysis Report By Application, By Region, and Segment Forecasts, 2025 - 2030

出版日期: 2024年11月05日 | 出版商:

Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

醫療保健生物融合市場成長與趨勢

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球醫療保健生物融合市場規模預計將達到 2,152 億美元。

由於老年人數量不斷增加、幹細胞技術在修復受損細胞、組織和器官、機器人技術、機械技術等方面的優勢，該市場預計從 2025 年到 2030 年將以 6.7% 的複合年成長率擴張。科技科技與學習、智慧成像、人體工學（個人與環境之間的關係）、人工智慧和生命科學的進步相結合。除了醫學之外，生物融合也應用於農業、能源、食品、安全和氣候等各個領域。

COVID-19 大流行對藥物研究、衛生技術和醫療技術產生了重大影響。將人工智慧和機器學習等高科技技術融入生物技術研發部門，有助於了解病原體並開發藥物和疫苗，以遏制病毒在世界各地的傳播。先進工程、生物學、物理學和計算科學的融合極大地加快了藥物開發的步伐。根據 2021 年學術論文《醫學前沿》，人工智慧等先進技術正在幫助 COVID-19 的高效診斷、預後測試、流行病預測和藥物發現。

隨著數位化進步的接受，雲端基礎的解決方案可能會在製藥業以指數速度發展。再生醫學透過融合生命科學、先進工程、機器人技術、電腦科學、自動化和專業知識來持續發展，為體內修復提供要素。

醫療保健生物融合市場報告亮點

按應用來看，藥物發現預計將在 2024 年佔據市場主導地位，收益佔有率為 20.46%，2025 年至 2030 年複合年成長率最快為 8.2%。背後的原因包括神經系統和循環系統疾病等多種疾病的發病率增加、醫療費用上漲以及普通藥品專利到期。
再生醫學領域因其在治療帕金森氏症、阿茲海默症、腦損傷組織修復等慢性病以及透過靶向、特異性、精準藥物治療慢性病方面的突出潛力，預計將在2025年實現成長到2030 年，交付量可能會創下8.7% 的最快複合年成長率。
2024年，歐洲將以30.13%的收益佔有率主導市場。這是由於領先的研究機構、醫院和醫療中心的存在，為識別和創造創新的醫學科學治療方法提供了堅實的基礎。

The global healthcare bioconvergence market size is expected to reach USD 215.2 billion by 2030, based on a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 6.7% from 2025 to 2030, owing to factors including the growing geriatric population, rising stem cell technology regarding the advantages of fixing damaged cells, tissues as well as organs, and the integration of high-tech technologies and advancements such as robotics, machine learning, intelligent imaging, ergonomics (relationship between individuals and their environment), and artificial intelligence with life science. Besides healthcare, bioconvergence is finding applications in a variety of other areas as well, including agriculture, energy, food, security, climate, and others.

The COVID-19 pandemic has significantly impacted medication research, health technology, and medical technology. The incorporation of high-tech technologies such as AI and ML into the biotech research and development sector aided in understanding the pathogen and developing drugs as well as vaccines to control the spread of the virus across the globe. The amalgamation of advanced engineering, biology, physics, and computational sciences, has significantly increased the pace of drug development. According to the 2021 academic paper Frontiers in Medicine, advanced technologies such as AI have helped in efficient diagnosis, prognosis examination, epidemic prediction, and drug discovery for COVID-19.

With the rise in terms of acceptance of digital advancements, cloud-based solutions are likely to evolve in the pharmaceutical industry at an exponential pace. Regenerative medicine is evolving by merging expertise knowledge with life science, advanced engineering, robotics, computer science, and automation to provide elements for in-vivo repair.

Healthcare Bioconvergence Market Report Highlights:

Based on application, drug discovery dominates dominated the market in terms of the revenue share of 20.46% in 2024 and is expected to witness the fastest CAGR of 8.2% from 2025 to 2030. This is attributable to the growing frequency of a broad range of ailments (such as nervous system-related disorders, and circulatory disorders), mounting medical costs, as well as the approaching patent termination of popular drugs
The regenerative medicine segment is likely to witness the fastest CAGR of 8.7% from 2025 to 2030 owing to its exceptional potential to treat chronic diseases such as Parkinson's disease, Alzheimer's disease, brain injury tissue repair, and to treat chronic diseases by target-oriented, and site-specific delivery of precise drugs
In 2024, Europe dominated the market with a revenue share of 30.13%, owing to the presence of leading research institutes, hospitals, and medical centers which serve a solid basis for identifying and creating innovative medical and scientific treatments

Chapter 1 Report Scope and Objectives

1.1 Market Segmentation & Scope
1.2 Regional Scope
- 1.2.1 Estimates And Forecast Timeline
1.3 Objectives
- 1.3.1 Objective - 1
- 1.3.2 Objective - 2
- 1.3.3 Objective - 3

Chapter 2 Methodology

2.1 Research Methodology
2.2 Information Procurement
- 2.2.1 Purchased Database
- 2.2.2 GVR's Internal Database
- 2.2.3 Secondary Sources
- 2.2.4 Primary Research
2.3 Information Or Data Analysis
- 2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
- 2.5.1 Commodity Flow Analysis (Model 1)
- 2.5.2 Volume Price Analysis (Model 2)
2.6 List Of Secondary Sources

Chapter 3 Executive Summary

3.1 Market Outlook
3.2 Segment Outlook
- 3.2.1 Application
- 3.2.4 Region
3.3 Competitive Insights
3.4 Healthcare Bioconvergence Market Outlook, 2024

Chapter 4 Market Variables, Trends & Scope

4.1 Market Lineage Outlook
- 4.1.1 Parent Market Outlook
4.2 Healthcare Bioconvergence Market Dynamics
- 4.2.1 Market Driver Analysis
- 4.2.2 Market Restraint Analysis
4.3 Healthcare Bioconvergence: Business Environment Analysis Tools
- 4.3.1 Porter's Five Forces Analysis
  - 4.3.1.1 Competitive Rivalry
  - 4.3.1.2 Threat Of Substitutes
  - 4.3.1.3 Threat Of Entrants
  - 4.3.1.4 Bargaining Power Of Buyers
  - 4.3.1.5 Bargaining Power Of Suppliers
- 4.3.2 Pestel Analysis
  - 4.3.2.1 Political & Legal
  - 4.3.2.2 Economic & Social
  - 4.3.2.3 Technological
4.4 Penetration & Growth Prospect Mapping
4.5 Impact Of COVID-19 On Healthcare Bioconvergence Market

Chapter 5 Healthcare Bioconvergence Market: Application Analysis

5.1 Healthcare Bioconvergence Application Market Share Analysis, 2024 & 2030
5.2 Healthcare Bioconvergence Application Market: Segment Dashboard
5.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Application Segment
- 5.3.1 Drug Discovery
  - 5.3.1.1 Drug Discovery Market, 2018 - 2030 (USD Million)
- 5.3.2 Nanorobotics For Drug Delivery
  - 5.3.2.1 Nanorobotics For Drug Delivery Market, 2018 - 2030 (USD Million)
- 5.3.3 Regenerative Medicine
  - 5.3.3.1 Regenerative Medicine Market, 2018 - 2030 (USD Million)
- 5.3.4 Diagnostic And Biological Sensors
  - 5.3.4.1 Diagnostic And Biological Sensors Market, 2018 - 2030 (USD Million)
- 5.3.5 Bioelectronics
  - 5.3.5.1 Bioelectronics Market, 2018 - 2030 (USD Million)
- 5.3.6 Engineered Living Materials
  - 5.3.6.1 Engineered Living Materials Market, 2018 - 2030 (USD Million)
- 5.3.7 Optogenetics
  - 5.3.7.1 Optogenetics Market, 2018 - 2030 (USD Million)
- 5.3.8 Precision Medicine
  - 5.3.8.1 Precision Medicine Market, 2018 - 2030 (USD Million)

Chapter 6 Healthcare Bioconvergence Market: Regional Analysis

6.1 Healthcare Bioconvergence Regional Market Share Analysis, 2024 & 2030
6.2 Regional Market Snapshot
6.3 North America
- 6.3.1 North America Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.2 U.S.
  - 6.3.2.1 U.S. Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.3 Canada
  - 6.3.3.1 Canada Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.4 Mexico
  - 6.3.4.1 Mexico Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
6.4 Europe
- 6.4.1 Europe Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.2 UK
  - 6.4.2.1 UK Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.3 Germany
  - 6.4.3.1 Germany Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.4 France
  - 6.4.4.1 France Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.5 Italy
  - 6.4.5.1 Italy Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.6 Spain
  - 6.4.6.1 Spain Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.7 Russia
  - 6.4.7.1 Russia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.8 Denmark
  - 6.3.8.1 Denmark Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.9 Sweden
  - 6.3.9.1 Sweden Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.10 Norway
  - 6.3.10.1 Norway Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
6.5 Asia Pacific
- 6.5.1 Asia Pacific Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.2 Japan
  - 6.5.2.1 Japan Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.3 China
  - 6.5.3.1 China Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.4 India
  - 6.5.4.1 India Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.5 Australia
  - 6.5.5.1 Australia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.6 South Korea
  - 6.5.6.1 South Korea Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.7 Singapore
  - 6.5.7.1 Singapore Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.8 Thailand
  - 6.5.8.1 Thailand Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
6.6 Latin America
- 6.6.1 Latin America Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.6.2 Brazil
  - 6.6.2.1 Brazil Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.6.3 Mexico
  - 6.6.3.1 Mexico Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.6.4 Argentina
  - 6.6.4.1 Argentina Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.6.5 Colombia
  - 6.6.5.1 Colombia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
6.7 Middle East And Africa (MEA)
- 6.7.1 MEA Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.7.2 South Africa
  - 6.7.2.1 South Africa Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.7.3 Saudi Arabia
  - 6.7.3.1 Saudi Arabia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.7.4 UAE
  - 6.7.4.1 UAE Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.7.5 Israel
  - 6.7.5.1 Israel Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.7.6 Kuwait
  - 6.7.6.1 Kuwait Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis

7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Profiles
- 7.2.1 Biomx.
  - 7.2.1.1 Company Overview
  - 7.2.1.2 Financial Performance
  - 7.2.1.2 Product Benchmarking
  - 7.2.1.3 Strategic Initiatives
- 7.2.2 Singota Solution
  - 7.2.2.1 Company Overview
  - 7.2.2.2 Product Benchmarking
- 7.2.3 Anima Biotech Inc.
  - 7.2.3.1 Company Overview
  - 7.2.3.3 Product Benchmarking
- 7.2.4 Ginkgo Bioworks
  - 7.2.4.1 Company Overview
  - 7.2.4.2 Product Benchmarking
  - 7.2.4.3 Strategic Initiatives
- 7.2.5 Setpoint Medical Corporation
  - 7.2.5.1 Company Overview
  - 7.2.5.2 Product Benchmarking
  - 7.2.5.3 Strategic Initiatives
- 7.2.6 Galvani Bioelectronics
  - 7.2.6.1 Company Overview
  - 7.2.6.2 Product Benchmarking
- 7.2.7 Bico - The Bio Convergence Company
  - 7.2.7.1 Company Overview
  - 7.2.7.2 Financial Performance
  - 7.2.7.3 Product Benchmarking
  - 7.2.7.4 Strategic Initiatives

簡介目錄圖表

List of Tables

Table 1 List of secondary sources
Table 2 North America healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 3 North America healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 4 U.S. healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 5 Canada healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 6 Mexico healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 7 Europe healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 8 Europe healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 9 UK healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 10 Germany healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 11 France healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 12 Italy healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 13 Spain healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 14 Russia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 15 Denmark healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 16 Sweden healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 17 Norway healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 18 Asia Pacific healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 19 Asia Pacific healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 20 Japan healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 21 China healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 22 India healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 23 Australia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 24 South Korea healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 25 Singapore healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 26 Thailand healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 27 Latin America healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 28 Latin America healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 29 Brazil healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 30 Argentina healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 31 Colombia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 32 MEA healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 33 MEA healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 34 South Africa healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 35 Saudi Arabia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 36 UAE healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 37 Israel healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 38 Kuwait healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Healthcare bioconvergence market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Healthcare bioconvergence market outlook, 2024 (USD Million)
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Healthcare bioconvergence application market share analysis, 2024 & 2030 (USD Million)
Fig. 15 Healthcare bioconvergence application market: Segment dashboard
Fig. 16 Drug discovery market, 2018 - 2030 (USD Million)
Fig. 17 Nanorobotics for drug delivery market, 2018 - 2030 (USD Million)x1
Fig. 18 Regenerative medicine market, 2018 - 2030 (USD Million)
Fig. 19 Diagnostic and biological sensors market, 2018 - 2030 (USD Million)
Fig. 20 Bioelectronics market, 2018 - 2030 (USD Million)
Fig. 21 Engineered living materials market, 2018 - 2030 (USD Million)
Fig. 22 Optogenetics market, 2018 - 2030 (USD Million)
Fig. 23 Precision medicine health market, 2018 - 2030 (USD Million)
Fig. 24 Healthcare bioconvergence regional market share analysis, 2021 & 2030 (USD Million)
Fig. 25 Regional market place: Key takeaways
Fig. 26 North America healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 27 U.S. healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 28 Canada healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 29 Mexico healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 30 Europe healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 31 UK healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 32 Germany healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 33 France healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 34 Italy healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 35 Spain healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 36 Russia healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 37 Denmark healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 38 Sweden healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 39 Norway healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 40 Asia Pacific healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 41 Japan healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 42 China healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 43 India healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 44 Australia healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 45 South Korea healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 46 Singapore healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 47 Thailand healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 48 Latin America healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 49 Brazil healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 50 Argentina healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 51 Colombia healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 52 MEA healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 53 South Africa healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 55 UAE healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 56 Israel healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 57 Israel healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 58 Strategy framework